- Home
- IBM vs NVO Comparison
IBM vs NVO Comparison
Compare IBM & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBM | NVO |
|---|---|---|
| Founded | 1911 | 1923 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.8B | 269.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IBM | NVO |
|---|---|---|
| Price | $289.82 | $43.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | ★ $319.71 | $54.25 |
| AVG Volume (30 Days) | 5.1M | ★ 25.0M |
| Earning Date | 01-28-2026 | 02-04-2026 |
| Dividend Yield | 2.33% | ★ 2.61% |
| EPS Growth | ★ 73.65 | 1.77 |
| EPS | ★ 11.16 | 3.62 |
| Revenue | ★ $67,535,000,000.00 | $48,588,245,669.00 |
| Revenue This Year | $4.90 | $1.02 |
| Revenue Next Year | $4.17 | $6.81 |
| P/E Ratio | $25.89 | ★ $13.03 |
| Revenue Growth | ★ 7.62 | 6.43 |
| 52 Week Low | $214.50 | $43.08 |
| 52 Week High | $324.90 | $93.80 |
Technical Indicators
Market Signals| Indicator | IBM | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 26.30 |
| Support Level | $278.96 | $57.56 |
| Resistance Level | $316.64 | $64.16 |
| Average True Range (ATR) | 9.33 | 2.36 |
| MACD | -0.74 | -2.21 |
| Stochastic Oscillator | 27.41 | 0.53 |
Price Performance
Historical ComparisonAbout IBM International Business Machines Corporation
Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world. It provides software, IT consulting services, and hardware to help business customers modernize their technology workflows. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which includes 95% of all Fortune 500 companies. IBM's products, including Red Hat, watsonx, and mainframes, handle some of the world's most important data workloads in areas like finance and retail.
About NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.